These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 8448586)
1. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. Matthews JS; Jones RL Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
3. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum. Lawrence RA; Jones RL; Wilson NH Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Lawrence RA; Jones RL Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890 [TBL] [Abstract][Full Text] [Related]
6. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Qian YM; Jones RL; Chan KM; Stock AI; Ho JK Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185 [TBL] [Abstract][Full Text] [Related]
7. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea. Lydford SJ; McKechnie K Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E receptors in myometrial cells. Asbóth G; Phaneuf S; López Bernal AL Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435 [TBL] [Abstract][Full Text] [Related]
10. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597 [TBL] [Abstract][Full Text] [Related]
11. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine. Shahbazian A; Heinemann A; Peskar BA; Holzer P Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Lydford SJ; McKechnie KC; Dougall IG Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337 [TBL] [Abstract][Full Text] [Related]
13. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Walch L; de Montpreville V; Brink C; Norel X Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243 [TBL] [Abstract][Full Text] [Related]
14. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S Platelets; 2010; 21(5):329-42. PubMed ID: 20433310 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype. Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911 [TBL] [Abstract][Full Text] [Related]
16. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. Crankshaw DJ; Gaspar V J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849 [TBL] [Abstract][Full Text] [Related]
18. Characterization of prostanoid receptors on rat neutrophils. Wise H; Jones RL Br J Pharmacol; 1994 Oct; 113(2):581-7. PubMed ID: 7834211 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements. Tymkewycz PM; Jones RL; Wilson NH; Marr CG Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Talpain E; Armstrong RA; Coleman RA; Vardey CJ Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]